ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0

CUSIP: 014339AA3

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Debt / NOTE 2.500% 2/0
Market price (% of par)
110.69%
Total 13F principal
$262,845,800
Principal change
-$18,225,000
Total reported market value
$300,059,481
Number of holders
26
Value change
-$11,043,783
Number of buys
15
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 014339AA3?
CUSIP 014339AA3 identifies 014339AA3 - ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0 as of Q3 2019

As of 30 Sep 2019, ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0 was held by 26 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $262,845,800 in principal (par value) of the bond. The largest 10 bondholders included Lion Point Capital, LP, WOLVERINE ASSET MANAGEMENT LLC, Redmile Group, LLC, UBS ASSET MANAGEMENT AMERICAS INC, CITADEL ADVISORS LLC, AMUNDI PIONEER ASSET MANAGEMENT INC, CSS LLC/IL, CAPSTONE INVESTMENT ADVISORS, LLC, LAZARD ASSET MANAGEMENT LLC, and CREDIT SUISSE AG/. This page lists 26 institutional bondholders reporting positions for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.